Fundraising Fox

Nephros

NASDAQ: NEPH

River Edge, US · Delaware corporation

Healthtech

Founders & leadership

DE
Daron EvansExecutive

Board

PM
Paul MieyalBoard director
AA
Arthur AmronBoard director
MR
Matthew RosenbergBoard director
LC
Lawrence CentellaBoard director
MP
Malcolm PersenBoard director

Reported raises · per SEC filings

Form D private placements

$10.7M disclosed across 6 rounds · 2015–2021

▶$2.1MraisedSep 2021 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew AstorExecutive Officer, Director
  • Arthur AmronDirector
  • Oliver SpandowDirector
  • Thomas GwydirDirector
  • Alisa LaskDirector
Offering amount
$2.4M
Amount sold
$2.1M
Proceeds to insiders
$100K
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJul 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alisa LaskDirector
  • Andrew AstorExecutive Officer, Director
  • Thomas GwydirDirector
  • Arthur AmronDirector
  • Malcolm PersonDirector
  • Oliver SpandowDirector
Offering amount
$1.2M
Amount sold
$1.2M
First sale
Jul 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMay 2019 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daron EvansExecutive Officer, Director
  • Andrew AstorExecutive Officer
  • Paul A. MieyalDirector
  • Thomas GwydirDirector
  • Malcolm C. PersenDirector
  • Oliver SpandowDirector
  • Alisa LaskDirector
  • Arthur H. AmronDirector
Offering amount
$2M
Amount sold
$2M
Proceeds to insiders
$100K
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedSep 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Moshe PintoDirector
  • Malcolm PersenDirector
  • Paul MieyalDirector
  • Arthur AmronDirector
  • Oliver SpandowDirector
  • Daron EvansExecutive Officer, Director
  • Andrew AstorExecutive Officer
Offering amount
$10.2M
Amount sold
$1.3M
Proceeds to insiders
$100K
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedApr 2018 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daron EvansExecutive Officer, Director
  • Moshe PintoDirector
  • Malcolm PersenDirector
  • Andrew AstorExecutive Officer
  • Paul MieyalDirector
  • Arthur AmronDirector
Offering amount
$2.9M
Amount sold
$2.9M
Proceeds to insiders
$100K
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedMay 2015 · 26 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew RosenbergDirector
  • Lawrence CentellaDirector
  • Paul MieyalDirector
  • Daron EvansExecutive Officer, Director
  • Malcolm PersenDirector
  • Arthur AmronDirector
Offering amount
$1.5M
Amount sold
$1.2M
Proceeds to insiders
$100K
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Nephros (NASDAQ:NEPH) Releases Earnings Results - Ticker Reporttickerreport.com · Aug 2026Earnings call transcript: Nephros posts Q2 2026 growth, shares rise premarket By Investing.cominvesting.com · Aug 2026Nephros sets July 16 virtual investor event | NEPH Stock Newsstocktitan.net · Jun 2026Investors | Nephrosnephros.com · Feb 2022Retina Implant closes $18 million round | Funding roundup - MassDevicemassdevice.com

Frequently asked questions

How much funding has Nephros raised?
Nephros has disclosed $10.7M raised across 6 rounds.
Where is Nephros headquartered?
Nephros is headquartered in River Edge, US.